|0.882 -0.011 (-1.21%)||12-07 16:00|
|Targets||6-month :||1.47||1-year :||1.77|
|Resists||First :||1.26||Second :||1.51|
|Supports||First :||0.83||Second :||0.69|
|MAs||MA(5) :||0.9||MA(20) :||0.98|
|MA(100) :||0.91||MA(250) :||0.93|
|MACD||MACD :||-0.1||Signal :||-0.1|
|%K %D||K(14,3) :||12.4||D(3) :||15.6|
|52-week||High :||4.75||Low :||0.24|
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ FEMY ] has closed above bottom band by 15.0%. Bollinger Bands are 80.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 7 bars. This is a sign that the market may be about to initiate a new trend.
|If tomorrow:||Open lower||Open higher|
|High:||0.9 - 0.91||0.91 - 0.91|
|Low:||0.86 - 0.86||0.86 - 0.87|
|Close:||0.87 - 0.88||0.88 - 0.89|
Femasys Inc., a biomedical company, focuses on women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; FemCerv, a biopsy device for endocervical curettage; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. It also commercializes FemVue saline-air device in the United States, Europe, Canada, Japan, and internationally. The company offers its infertility products to obstetrics-gynecological physicians, related healthcare professionals, women's healthcare provider organizations, and reproductive endocrinologists. In addition, it provides non-surgical product technologies. Femasys Inc. was incorporated in 2004 and is based in Suwanee, Georgia.
Tue, 28 Nov 2023
Femasys: Ready To Turn The Corner (NASDAQ:FEMY) - Seeking Alpha
|Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
|Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
|Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
|Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
|Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
|Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Medical Instruments & Supplies
|Shares Out||0 (M)|
|Shares Float||22 (M)|
|Held by Insiders||1.941e+007 (%)|
|Held by Institutions||14.8 (%)|
|Shares Short||1,290 (K)|
|Shares Short P.Month||0 (K)|
|EPS Est Next Qtrly||0|
|EPS Est This Year||0|
|EPS Est Next Year||0|
|Book Value (p.s.)||0|
|Profit Margin||0 %|
|Operating Margin||-1 %|
|Return on Assets (ttm)||670.1 %|
|Return on Equity (ttm)||-46.8 %|
|Qtrly Rev. Growth||1.09e+006 %|
|Gross Profit (p.s.)||0.04|
|Sales Per Share||0.07|
|Qtrly Earnings Growth||-1 %|
|Operating Cash Flow||0 (M)|
|Levered Free Cash Flow||-11 (M)|
|Price to Book value||0|
|Price to Sales||12.37|
|Price to Cash Flow||-4.81|
|Dividend Pay Date||Invalid DateTime.|
|Ex-Dividend Date||Invalid DateTime.|